Global Antiandrogen Monotherapy Industry Research Report, Competitive Landscape, Market Size, Regional Status and Prospect
The report combines extensive quantitative analysis and exhaustive qualitative analysis, ranges from a macro overview of the total market size, industry chain, and market dynamics to micro details of segment markets by type, application and region, and, as a result, provides a holistic view of, as well as a deep insight into the Antiandrogen Monotherapy market covering all its essential aspects.
For the competitive landscape, the report also introduces players in the industry from the perspective of the market share, concentration ratio, etc., and describes the leading companies in detail, with which the readers can get a better idea of their competitors and acquire an in-depth understanding of the competitive situation. Further, mergers & acquisitions, emerging market trends, the impact of COVID-19, and regional conflicts will all be considered.
In a nutshell, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the market in any manner.
Key players in the global Antiandrogen Monotherapy market are covered in Chapter 9:
Abbott Laboratories
Progenics Pharmaceuticals, Inc.
ANI Pharmaceuticals, Inc.
Sanofi SA
Novartis AG
Pfizer Inc.
GlaxoSmithKline Plc
Genentech Inc.
Bristol-Myers Squibb Company
Astellas Pharma Inc.
ALZA Corporation
Takeda Pharmaceutical Company Limited
Amgen Inc
F. Hoffmann-La Roche Ltd.
AstraZeneca Plc
OSI Pharmaceuticals, Inc.
In Chapter 5 and Chapter 7.3, based on types, the Antiandrogen Monotherapy market from 2017 to 2027 is primarily split into:
Steroidal
Nonsteroidal
In Chapter 6 and Chapter 7.4, based on applications, the Antiandrogen Monotherapy market from 2017 to 2027 covers:
Prostate Cancer
Benign Prostatic Hyperplasia
Hirsutism
Hyperandrogenism
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2017-2027) of the following regions are covered in Chapter 4 and Chapter 7:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Client Focus
1. Does this report consider the impact of COVID-19 and the Russia-Ukraine war on the Antiandrogen Monotherapy market?
Yes. As the COVID-19 and the Russia-Ukraine war are profoundly affecting the global supply chain relationship and raw material price system, we have definitely taken them into consideration throughout the research, and in Chapters 1.7, 2.7, 4.X.1, 7.5, 8.7, we elaborate at full length on the impact of the pandemic and the war on the Antiandrogen Monotherapy Industry.
2. How do you determine the list of the key players included in the report?
With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth.
Please find the key player list in Summary.
3. What are your main data sources?
Both Primary and Secondary data sources are being used while compiling the report.
Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users.
Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.
Please find a more complete list of data sources in Chapters 11.2.1 & 11.2.2.
4. Can I modify the scope of the report and customize it to suit my requirements?
Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus to win them sufficient time and space for market competition.
Outline
Chapter 1 mainly defines the market scope and introduces the macro overview of the industry, with an executive summary of different market segments ((by type, application, region, etc.), including the definition, market size, and trend of each market segment.
Chapter 2 provides a qualitative analysis of the current status and future trends of the market. Industry Entry Barriers, market drivers, market challenges, emerging markets, consumer preference analysis, together with the impact of the COVID-19 outbreak will all be thoroughly explained.
Chapter 3 analyzes the current competitive situation of the market by providing data regarding the players, including their sales volume and revenue with corresponding market shares, price and gross margin. In addition, information about market concentration ratio, mergers, acquisitions, and expansion plans will also be covered.
Chapter 4 focuses on the regional market, presenting detailed data (i.e., sales volume, revenue, price, gross margin) of the most representative regions and countries in the world.
Chapter 5 provides the analysis of various market segments according to product types, covering sales volume, revenue along with market share and growth rate, plus the price analysis of each type.
Chapter 6 shows the breakdown data of different applications, including the consumption and revenue with market share and growth rate, with the aim of helping the readers to take a close-up look at the downstream market.
Chapter 7 provides a combination of quantitative and qualitative analyses of the market size and development trends in the next five years. The forecast information of the whole, as well as the breakdown market, offers the readers a chance to look into the future of the industry.
Chapter 8 is the analysis of the whole market industrial chain, covering key raw materials suppliers and price analysis, manufacturing cost structure analysis, alternative product analysis, also providing information on major distributors, downstream buyers, and the impact of COVID-19 pandemic.
Chapter 9 shares a list of the key players in the market, together with their basic information, product profiles, market performance (i.e., sales volume, price, revenue, gross margin), recent development, SWOT analysis, etc.
Chapter 10 is the conclusion of the report which helps the readers to sum up the main findings and points.
Chapter 11 introduces the market research methods and data sources.
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2027
1 ANTIANDROGEN MONOTHERAPY MARKET OVERVIEW
1.1 Product Overview and Scope of Antiandrogen Monotherapy Market
1.2 Antiandrogen Monotherapy Market Segment by Type
1.2.1 Global Antiandrogen Monotherapy Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Antiandrogen Monotherapy Market Segment by Application
1.3.1 Antiandrogen Monotherapy Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Antiandrogen Monotherapy Market, Region Wise (2017-2027)
1.4.1 Global Antiandrogen Monotherapy Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
1.4.2 United States Antiandrogen Monotherapy Market Status and Prospect (2017-2027)
1.4.3 Europe Antiandrogen Monotherapy Market Status and Prospect (2017-2027)
1.4.4 China Antiandrogen Monotherapy Market Status and Prospect (2017-2027)
1.4.5 Japan Antiandrogen Monotherapy Market Status and Prospect (2017-2027)
1.4.6 India Antiandrogen Monotherapy Market Status and Prospect (2017-2027)
1.4.7 Southeast Asia Antiandrogen Monotherapy Market Status and Prospect (2017-2027)
1.4.8 Latin America Antiandrogen Monotherapy Market Status and Prospect (2017-2027)
1.4.9 Middle East and Africa Antiandrogen Monotherapy Market Status and Prospect (2017-2027)
1.5 Global Market Size of Antiandrogen Monotherapy (2017-2027)
1.5.1 Global Antiandrogen Monotherapy Market Revenue Status and Outlook (2017-2027)
1.5.2 Global Antiandrogen Monotherapy Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Antiandrogen Monotherapy Market
2 INDUSTRY OUTLOOK
2.1 Antiandrogen Monotherapy Industry Technology Status and Trends
2.2 Industry Entry Barriers
2.2.1 Analysis of Financial Barriers
2.2.2 Analysis of Technical Barriers
2.2.3 Analysis of Talent Barriers
2.2.4 Analysis of Brand Barrier
2.3 Antiandrogen Monotherapy Market Drivers Analysis
2.4 Antiandrogen Monotherapy Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Antiandrogen Monotherapy Industry Development Trends under COVID-19 Outbreak
2.7.1 Global COVID-19 Status Overview
2.7.2 Influence of COVID-19 Outbreak on Antiandrogen Monotherapy Industry Development
3 GLOBAL ANTIANDROGEN MONOTHERAPY MARKET LANDSCAPE BY PLAYER
3.1 Global Antiandrogen Monotherapy Sales Volume and Share by Player (2017-2022)
3.2 Global Antiandrogen Monotherapy Revenue and Market Share by Player (2017-2022)
3.3 Global Antiandrogen Monotherapy Average Price by Player (2017-2022)
3.4 Global Antiandrogen Monotherapy Gross Margin by Player (2017-2022)
3.5 Antiandrogen Monotherapy Market Competitive Situation and Trends
3.5.1 Antiandrogen Monotherapy Market Concentration Rate
3.5.2 Antiandrogen Monotherapy Market Share of Top 3 and Top 6 Players
3.5.3 Mergers & Acquisitions, Expansion
4 GLOBAL ANTIANDROGEN MONOTHERAPY SALES VOLUME AND REVENUE REGION WISE (2017-2022)
4.1 Global Antiandrogen Monotherapy Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Antiandrogen Monotherapy Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Antiandrogen Monotherapy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Antiandrogen Monotherapy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4.1 United States Antiandrogen Monotherapy Market Under COVID-19
4.5 Europe Antiandrogen Monotherapy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.5.1 Europe Antiandrogen Monotherapy Market Under COVID-19
4.6 China Antiandrogen Monotherapy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.6.1 China Antiandrogen Monotherapy Market Under COVID-19
4.7 Japan Antiandrogen Monotherapy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.7.1 Japan Antiandrogen Monotherapy Market Under COVID-19
4.8 India Antiandrogen Monotherapy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.8.1 India Antiandrogen Monotherapy Market Under COVID-19
4.9 Southeast Asia Antiandrogen Monotherapy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.9.1 Southeast Asia Antiandrogen Monotherapy Market Under COVID-19
4.10 Latin America Antiandrogen Monotherapy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.10.1 Latin America Antiandrogen Monotherapy Market Under COVID-19
4.11 Middle East and Africa Antiandrogen Monotherapy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.11.1 Middle East and Africa Antiandrogen Monotherapy Market Under COVID-19
5 GLOBAL ANTIANDROGEN MONOTHERAPY SALES VOLUME, REVENUE, PRICE TREND BY TYPE
5.1 Global Antiandrogen Monotherapy Sales Volume and Market Share by Type (2017-2022)
5.2 Global Antiandrogen Monotherapy Revenue and Market Share by Type (2017-2022)
5.3 Global Antiandrogen Monotherapy Price by Type (2017-2022)
5.4 Global Antiandrogen Monotherapy Sales Volume, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Antiandrogen Monotherapy Sales Volume, Revenue and Growth Rate of Steroidal (2017-2022)
5.4.2 Global Antiandrogen Monotherapy Sales Volume, Revenue and Growth Rate of Nonsteroidal (2017-2022)
6 GLOBAL ANTIANDROGEN MONOTHERAPY MARKET ANALYSIS BY APPLICATION
6.1 Global Antiandrogen Monotherapy Consumption and Market Share by Application (2017-2022)
6.2 Global Antiandrogen Monotherapy Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Antiandrogen Monotherapy Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Antiandrogen Monotherapy Consumption and Growth Rate of Prostate Cancer (2017-2022)
6.3.2 Global Antiandrogen Monotherapy Consumption and Growth Rate of Benign Prostatic Hyperplasia (2017-2022)
6.3.3 Global Antiandrogen Monotherapy Consumption and Growth Rate of Hirsutism (2017-2022)
6.3.4 Global Antiandrogen Monotherapy Consumption and Growth Rate of Hyperandrogenism (2017-2022)
6.3.5 Global Antiandrogen Monotherapy Consumption and Growth Rate of Others (2017-2022)
7 GLOBAL ANTIANDROGEN MONOTHERAPY MARKET FORECAST (2022-2027)
7.1 Global Antiandrogen Monotherapy Sales Volume, Revenue Forecast (2022-2027)
7.1.1 Global Antiandrogen Monotherapy Sales Volume and Growth Rate Forecast (2022-2027)
7.1.2 Global Antiandrogen Monotherapy Revenue and Growth Rate Forecast (2022-2027)
7.1.3 Global Antiandrogen Monotherapy Price and Trend Forecast (2022-2027)
7.2 Global Antiandrogen Monotherapy Sales Volume and Revenue Forecast, Region Wise (2022-2027)
7.2.1 United States Antiandrogen Monotherapy Sales Volume and Revenue Forecast (2022-2027)
7.2.2 Europe Antiandrogen Monotherapy Sales Volume and Revenue Forecast (2022-2027)
7.2.3 China Antiandrogen Monotherapy Sales Volume and Revenue Forecast (2022-2027)
7.2.4 Japan Antiandrogen Monotherapy Sales Volume and Revenue Forecast (2022-2027)
7.2.5 India Antiandrogen Monotherapy Sales Volume and Revenue Forecast (2022-2027)
7.2.6 Southeast Asia Antiandrogen Monotherapy Sales Volume and Revenue Forecast (2022-2027)
7.2.7 Latin America Antiandrogen Monotherapy Sales Volume and Revenue Forecast (2022-2027)
7.2.8 Middle East and Africa Antiandrogen Monotherapy Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Antiandrogen Monotherapy Sales Volume, Revenue and Price Forecast by Type (2022-2027)
7.3.1 Global Antiandrogen Monotherapy Revenue and Growth Rate of Steroidal (2022-2027)
7.3.2 Global Antiandrogen Monotherapy Revenue and Growth Rate of Nonsteroidal (2022-2027)
7.4 Global Antiandrogen Monotherapy Consumption Forecast by Application (2022-2027)
7.4.1 Global Antiandrogen Monotherapy Consumption Value and Growth Rate of Prostate Cancer(2022-2027)
7.4.2 Global Antiandrogen Monotherapy Consumption Value and Growth Rate of Benign Prostatic Hyperplasia(2022-2027)
7.4.3 Global Antiandrogen Monotherapy Consumption Value and Growth Rate of Hirsutism(2022-2027)
7.4.4 Global Antiandrogen Monotherapy Consumption Value and Growth Rate of Hyperandrogenism(2022-2027)
7.4.5 Global Antiandrogen Monotherapy Consumption Value and Growth Rate of Others(2022-2027)
7.5 Antiandrogen Monotherapy Market Forecast Under COVID-19
8 ANTIANDROGEN MONOTHERAPY MARKET UPSTREAM AND DOWNSTREAM ANALYSIS
8.1 Antiandrogen Monotherapy Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
8.3.1 Labor Cost Analysis
8.3.2 Energy Costs Analysis
8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Antiandrogen Monotherapy Analysis
8.6 Major Downstream Buyers of Antiandrogen Monotherapy Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Antiandrogen Monotherapy Industry
9 PLAYERS PROFILES
9.1 Abbott Laboratories
9.1.1 Abbott Laboratories Basic Information, Manufacturing Base, Sales Region and Competitors
9.1.2 Antiandrogen Monotherapy Product Profiles, Application and Specification
9.1.3 Abbott Laboratories Market Performance (2017-2022)
9.1.4 Recent Development
9.1.5 SWOT Analysis
9.2 Progenics Pharmaceuticals, Inc.
9.2.1 Progenics Pharmaceuticals, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.2.2 Antiandrogen Monotherapy Product Profiles, Application and Specification
9.2.3 Progenics Pharmaceuticals, Inc. Market Performance (2017-2022)
9.2.4 Recent Development
9.2.5 SWOT Analysis
9.3 ANI Pharmaceuticals, Inc.
9.3.1 ANI Pharmaceuticals, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.3.2 Antiandrogen Monotherapy Product Profiles, Application and Specification
9.3.3 ANI Pharmaceuticals, Inc. Market Performance (2017-2022)
9.3.4 Recent Development
9.3.5 SWOT Analysis
9.4 Sanofi SA
9.4.1 Sanofi SA Basic Information, Manufacturing Base, Sales Region and Competitors
9.4.2 Antiandrogen Monotherapy Product Profiles, Application and Specification
9.4.3 Sanofi SA Market Performance (2017-2022)
9.4.4 Recent Development
9.4.5 SWOT Analysis
9.5 Novartis AG
9.5.1 Novartis AG Basic Information, Manufacturing Base, Sales Region and Competitors
9.5.2 Antiandrogen Monotherapy Product Profiles, Application and Specification
9.5.3 Novartis AG Market Performance (2017-2022)
9.5.4 Recent Development
9.5.5 SWOT Analysis
9.6 Pfizer Inc.
9.6.1 Pfizer Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.6.2 Antiandrogen Monotherapy Product Profiles, Application and Specification
9.6.3 Pfizer Inc. Market Performance (2017-2022)
9.6.4 Recent Development
9.6.5 SWOT Analysis
9.7 GlaxoSmithKline Plc
9.7.1 GlaxoSmithKline Plc Basic Information, Manufacturing Base, Sales Region and Competitors
9.7.2 Antiandrogen Monotherapy Product Profiles, Application and Specification
9.7.3 GlaxoSmithKline Plc Market Performance (2017-2022)
9.7.4 Recent Development
9.7.5 SWOT Analysis
9.8 Genentech Inc.
9.8.1 Genentech Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.8.2 Antiandrogen Monotherapy Product Profiles, Application and Specification
9.8.3 Genentech Inc. Market Performance (2017-2022)
9.8.4 Recent Development
9.8.5 SWOT Analysis
9.9 Bristol-Myers Squibb Company
9.9.1 Bristol-Myers Squibb Company Basic Information, Manufacturing Base, Sales Region and Competitors
9.9.2 Antiandrogen Monotherapy Product Profiles, Application and Specification
9.9.3 Bristol-Myers Squibb Company Market Performance (2017-2022)
9.9.4 Recent Development
9.9.5 SWOT Analysis
9.10 Astellas Pharma Inc.
9.10.1 Astellas Pharma Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.10.2 Antiandrogen Monotherapy Product Profiles, Application and Specification
9.10.3 Astellas Pharma Inc. Market Performance (2017-2022)
9.10.4 Recent Development
9.10.5 SWOT Analysis
9.11 ALZA Corporation
9.11.1 ALZA Corporation Basic Information, Manufacturing Base, Sales Region and Competitors
9.11.2 Antiandrogen Monotherapy Product Profiles, Application and Specification
9.11.3 ALZA Corporation Market Performance (2017-2022)
9.11.4 Recent Development
9.11.5 SWOT Analysis
9.12 Takeda Pharmaceutical Company Limited
9.12.1 Takeda Pharmaceutical Company Limited Basic Information, Manufacturing Base, Sales Region and Competitors
9.12.2 Antiandrogen Monotherapy Product Profiles, Application and Specification
9.12.3 Takeda Pharmaceutical Company Limited Market Performance (2017-2022)
9.12.4 Recent Development
9.12.5 SWOT Analysis
9.13 Amgen Inc
9.13.1 Amgen Inc Basic Information, Manufacturing Base, Sales Region and Competitors
9.13.2 Antiandrogen Monotherapy Product Profiles, Application and Specification
9.13.3 Amgen Inc Market Performance (2017-2022)
9.13.4 Recent Development
9.13.5 SWOT Analysis
9.14 F. Hoffmann-La Roche Ltd.
9.14.1 F. Hoffmann-La Roche Ltd. Basic Information, Manufacturing Base, Sales Region and Competitors
9.14.2 Antiandrogen Monotherapy Product Profiles, Application and Specification
9.14.3 F. Hoffmann-La Roche Ltd. Market Performance (2017-2022)
9.14.4 Recent Development
9.14.5 SWOT Analysis
9.15 AstraZeneca Plc
9.15.1 AstraZeneca Plc Basic Information, Manufacturing Base, Sales Region and Competitors
9.15.2 Antiandrogen Monotherapy Product Profiles, Application and Specification
9.15.3 AstraZeneca Plc Market Performance (2017-2022)
9.15.4 Recent Development
9.15.5 SWOT Analysis
9.16 OSI Pharmaceuticals, Inc.
9.16.1 OSI Pharmaceuticals, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.16.2 Antiandrogen Monotherapy Product Profiles, Application and Specification
9.16.3 OSI Pharmaceuticals, Inc. Market Performance (2017-2022)
9.16.4 Recent Development
9.16.5 SWOT Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Data Source
1.1 Product Overview and Scope of Antiandrogen Monotherapy Market
1.2 Antiandrogen Monotherapy Market Segment by Type
1.2.1 Global Antiandrogen Monotherapy Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Antiandrogen Monotherapy Market Segment by Application
1.3.1 Antiandrogen Monotherapy Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Antiandrogen Monotherapy Market, Region Wise (2017-2027)
1.4.1 Global Antiandrogen Monotherapy Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
1.4.2 United States Antiandrogen Monotherapy Market Status and Prospect (2017-2027)
1.4.3 Europe Antiandrogen Monotherapy Market Status and Prospect (2017-2027)
1.4.4 China Antiandrogen Monotherapy Market Status and Prospect (2017-2027)
1.4.5 Japan Antiandrogen Monotherapy Market Status and Prospect (2017-2027)
1.4.6 India Antiandrogen Monotherapy Market Status and Prospect (2017-2027)
1.4.7 Southeast Asia Antiandrogen Monotherapy Market Status and Prospect (2017-2027)
1.4.8 Latin America Antiandrogen Monotherapy Market Status and Prospect (2017-2027)
1.4.9 Middle East and Africa Antiandrogen Monotherapy Market Status and Prospect (2017-2027)
1.5 Global Market Size of Antiandrogen Monotherapy (2017-2027)
1.5.1 Global Antiandrogen Monotherapy Market Revenue Status and Outlook (2017-2027)
1.5.2 Global Antiandrogen Monotherapy Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Antiandrogen Monotherapy Market
2 INDUSTRY OUTLOOK
2.1 Antiandrogen Monotherapy Industry Technology Status and Trends
2.2 Industry Entry Barriers
2.2.1 Analysis of Financial Barriers
2.2.2 Analysis of Technical Barriers
2.2.3 Analysis of Talent Barriers
2.2.4 Analysis of Brand Barrier
2.3 Antiandrogen Monotherapy Market Drivers Analysis
2.4 Antiandrogen Monotherapy Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Antiandrogen Monotherapy Industry Development Trends under COVID-19 Outbreak
2.7.1 Global COVID-19 Status Overview
2.7.2 Influence of COVID-19 Outbreak on Antiandrogen Monotherapy Industry Development
3 GLOBAL ANTIANDROGEN MONOTHERAPY MARKET LANDSCAPE BY PLAYER
3.1 Global Antiandrogen Monotherapy Sales Volume and Share by Player (2017-2022)
3.2 Global Antiandrogen Monotherapy Revenue and Market Share by Player (2017-2022)
3.3 Global Antiandrogen Monotherapy Average Price by Player (2017-2022)
3.4 Global Antiandrogen Monotherapy Gross Margin by Player (2017-2022)
3.5 Antiandrogen Monotherapy Market Competitive Situation and Trends
3.5.1 Antiandrogen Monotherapy Market Concentration Rate
3.5.2 Antiandrogen Monotherapy Market Share of Top 3 and Top 6 Players
3.5.3 Mergers & Acquisitions, Expansion
4 GLOBAL ANTIANDROGEN MONOTHERAPY SALES VOLUME AND REVENUE REGION WISE (2017-2022)
4.1 Global Antiandrogen Monotherapy Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Antiandrogen Monotherapy Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Antiandrogen Monotherapy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Antiandrogen Monotherapy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4.1 United States Antiandrogen Monotherapy Market Under COVID-19
4.5 Europe Antiandrogen Monotherapy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.5.1 Europe Antiandrogen Monotherapy Market Under COVID-19
4.6 China Antiandrogen Monotherapy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.6.1 China Antiandrogen Monotherapy Market Under COVID-19
4.7 Japan Antiandrogen Monotherapy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.7.1 Japan Antiandrogen Monotherapy Market Under COVID-19
4.8 India Antiandrogen Monotherapy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.8.1 India Antiandrogen Monotherapy Market Under COVID-19
4.9 Southeast Asia Antiandrogen Monotherapy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.9.1 Southeast Asia Antiandrogen Monotherapy Market Under COVID-19
4.10 Latin America Antiandrogen Monotherapy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.10.1 Latin America Antiandrogen Monotherapy Market Under COVID-19
4.11 Middle East and Africa Antiandrogen Monotherapy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.11.1 Middle East and Africa Antiandrogen Monotherapy Market Under COVID-19
5 GLOBAL ANTIANDROGEN MONOTHERAPY SALES VOLUME, REVENUE, PRICE TREND BY TYPE
5.1 Global Antiandrogen Monotherapy Sales Volume and Market Share by Type (2017-2022)
5.2 Global Antiandrogen Monotherapy Revenue and Market Share by Type (2017-2022)
5.3 Global Antiandrogen Monotherapy Price by Type (2017-2022)
5.4 Global Antiandrogen Monotherapy Sales Volume, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Antiandrogen Monotherapy Sales Volume, Revenue and Growth Rate of Steroidal (2017-2022)
5.4.2 Global Antiandrogen Monotherapy Sales Volume, Revenue and Growth Rate of Nonsteroidal (2017-2022)
6 GLOBAL ANTIANDROGEN MONOTHERAPY MARKET ANALYSIS BY APPLICATION
6.1 Global Antiandrogen Monotherapy Consumption and Market Share by Application (2017-2022)
6.2 Global Antiandrogen Monotherapy Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Antiandrogen Monotherapy Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Antiandrogen Monotherapy Consumption and Growth Rate of Prostate Cancer (2017-2022)
6.3.2 Global Antiandrogen Monotherapy Consumption and Growth Rate of Benign Prostatic Hyperplasia (2017-2022)
6.3.3 Global Antiandrogen Monotherapy Consumption and Growth Rate of Hirsutism (2017-2022)
6.3.4 Global Antiandrogen Monotherapy Consumption and Growth Rate of Hyperandrogenism (2017-2022)
6.3.5 Global Antiandrogen Monotherapy Consumption and Growth Rate of Others (2017-2022)
7 GLOBAL ANTIANDROGEN MONOTHERAPY MARKET FORECAST (2022-2027)
7.1 Global Antiandrogen Monotherapy Sales Volume, Revenue Forecast (2022-2027)
7.1.1 Global Antiandrogen Monotherapy Sales Volume and Growth Rate Forecast (2022-2027)
7.1.2 Global Antiandrogen Monotherapy Revenue and Growth Rate Forecast (2022-2027)
7.1.3 Global Antiandrogen Monotherapy Price and Trend Forecast (2022-2027)
7.2 Global Antiandrogen Monotherapy Sales Volume and Revenue Forecast, Region Wise (2022-2027)
7.2.1 United States Antiandrogen Monotherapy Sales Volume and Revenue Forecast (2022-2027)
7.2.2 Europe Antiandrogen Monotherapy Sales Volume and Revenue Forecast (2022-2027)
7.2.3 China Antiandrogen Monotherapy Sales Volume and Revenue Forecast (2022-2027)
7.2.4 Japan Antiandrogen Monotherapy Sales Volume and Revenue Forecast (2022-2027)
7.2.5 India Antiandrogen Monotherapy Sales Volume and Revenue Forecast (2022-2027)
7.2.6 Southeast Asia Antiandrogen Monotherapy Sales Volume and Revenue Forecast (2022-2027)
7.2.7 Latin America Antiandrogen Monotherapy Sales Volume and Revenue Forecast (2022-2027)
7.2.8 Middle East and Africa Antiandrogen Monotherapy Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Antiandrogen Monotherapy Sales Volume, Revenue and Price Forecast by Type (2022-2027)
7.3.1 Global Antiandrogen Monotherapy Revenue and Growth Rate of Steroidal (2022-2027)
7.3.2 Global Antiandrogen Monotherapy Revenue and Growth Rate of Nonsteroidal (2022-2027)
7.4 Global Antiandrogen Monotherapy Consumption Forecast by Application (2022-2027)
7.4.1 Global Antiandrogen Monotherapy Consumption Value and Growth Rate of Prostate Cancer(2022-2027)
7.4.2 Global Antiandrogen Monotherapy Consumption Value and Growth Rate of Benign Prostatic Hyperplasia(2022-2027)
7.4.3 Global Antiandrogen Monotherapy Consumption Value and Growth Rate of Hirsutism(2022-2027)
7.4.4 Global Antiandrogen Monotherapy Consumption Value and Growth Rate of Hyperandrogenism(2022-2027)
7.4.5 Global Antiandrogen Monotherapy Consumption Value and Growth Rate of Others(2022-2027)
7.5 Antiandrogen Monotherapy Market Forecast Under COVID-19
8 ANTIANDROGEN MONOTHERAPY MARKET UPSTREAM AND DOWNSTREAM ANALYSIS
8.1 Antiandrogen Monotherapy Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
8.3.1 Labor Cost Analysis
8.3.2 Energy Costs Analysis
8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Antiandrogen Monotherapy Analysis
8.6 Major Downstream Buyers of Antiandrogen Monotherapy Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Antiandrogen Monotherapy Industry
9 PLAYERS PROFILES
9.1 Abbott Laboratories
9.1.1 Abbott Laboratories Basic Information, Manufacturing Base, Sales Region and Competitors
9.1.2 Antiandrogen Monotherapy Product Profiles, Application and Specification
9.1.3 Abbott Laboratories Market Performance (2017-2022)
9.1.4 Recent Development
9.1.5 SWOT Analysis
9.2 Progenics Pharmaceuticals, Inc.
9.2.1 Progenics Pharmaceuticals, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.2.2 Antiandrogen Monotherapy Product Profiles, Application and Specification
9.2.3 Progenics Pharmaceuticals, Inc. Market Performance (2017-2022)
9.2.4 Recent Development
9.2.5 SWOT Analysis
9.3 ANI Pharmaceuticals, Inc.
9.3.1 ANI Pharmaceuticals, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.3.2 Antiandrogen Monotherapy Product Profiles, Application and Specification
9.3.3 ANI Pharmaceuticals, Inc. Market Performance (2017-2022)
9.3.4 Recent Development
9.3.5 SWOT Analysis
9.4 Sanofi SA
9.4.1 Sanofi SA Basic Information, Manufacturing Base, Sales Region and Competitors
9.4.2 Antiandrogen Monotherapy Product Profiles, Application and Specification
9.4.3 Sanofi SA Market Performance (2017-2022)
9.4.4 Recent Development
9.4.5 SWOT Analysis
9.5 Novartis AG
9.5.1 Novartis AG Basic Information, Manufacturing Base, Sales Region and Competitors
9.5.2 Antiandrogen Monotherapy Product Profiles, Application and Specification
9.5.3 Novartis AG Market Performance (2017-2022)
9.5.4 Recent Development
9.5.5 SWOT Analysis
9.6 Pfizer Inc.
9.6.1 Pfizer Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.6.2 Antiandrogen Monotherapy Product Profiles, Application and Specification
9.6.3 Pfizer Inc. Market Performance (2017-2022)
9.6.4 Recent Development
9.6.5 SWOT Analysis
9.7 GlaxoSmithKline Plc
9.7.1 GlaxoSmithKline Plc Basic Information, Manufacturing Base, Sales Region and Competitors
9.7.2 Antiandrogen Monotherapy Product Profiles, Application and Specification
9.7.3 GlaxoSmithKline Plc Market Performance (2017-2022)
9.7.4 Recent Development
9.7.5 SWOT Analysis
9.8 Genentech Inc.
9.8.1 Genentech Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.8.2 Antiandrogen Monotherapy Product Profiles, Application and Specification
9.8.3 Genentech Inc. Market Performance (2017-2022)
9.8.4 Recent Development
9.8.5 SWOT Analysis
9.9 Bristol-Myers Squibb Company
9.9.1 Bristol-Myers Squibb Company Basic Information, Manufacturing Base, Sales Region and Competitors
9.9.2 Antiandrogen Monotherapy Product Profiles, Application and Specification
9.9.3 Bristol-Myers Squibb Company Market Performance (2017-2022)
9.9.4 Recent Development
9.9.5 SWOT Analysis
9.10 Astellas Pharma Inc.
9.10.1 Astellas Pharma Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.10.2 Antiandrogen Monotherapy Product Profiles, Application and Specification
9.10.3 Astellas Pharma Inc. Market Performance (2017-2022)
9.10.4 Recent Development
9.10.5 SWOT Analysis
9.11 ALZA Corporation
9.11.1 ALZA Corporation Basic Information, Manufacturing Base, Sales Region and Competitors
9.11.2 Antiandrogen Monotherapy Product Profiles, Application and Specification
9.11.3 ALZA Corporation Market Performance (2017-2022)
9.11.4 Recent Development
9.11.5 SWOT Analysis
9.12 Takeda Pharmaceutical Company Limited
9.12.1 Takeda Pharmaceutical Company Limited Basic Information, Manufacturing Base, Sales Region and Competitors
9.12.2 Antiandrogen Monotherapy Product Profiles, Application and Specification
9.12.3 Takeda Pharmaceutical Company Limited Market Performance (2017-2022)
9.12.4 Recent Development
9.12.5 SWOT Analysis
9.13 Amgen Inc
9.13.1 Amgen Inc Basic Information, Manufacturing Base, Sales Region and Competitors
9.13.2 Antiandrogen Monotherapy Product Profiles, Application and Specification
9.13.3 Amgen Inc Market Performance (2017-2022)
9.13.4 Recent Development
9.13.5 SWOT Analysis
9.14 F. Hoffmann-La Roche Ltd.
9.14.1 F. Hoffmann-La Roche Ltd. Basic Information, Manufacturing Base, Sales Region and Competitors
9.14.2 Antiandrogen Monotherapy Product Profiles, Application and Specification
9.14.3 F. Hoffmann-La Roche Ltd. Market Performance (2017-2022)
9.14.4 Recent Development
9.14.5 SWOT Analysis
9.15 AstraZeneca Plc
9.15.1 AstraZeneca Plc Basic Information, Manufacturing Base, Sales Region and Competitors
9.15.2 Antiandrogen Monotherapy Product Profiles, Application and Specification
9.15.3 AstraZeneca Plc Market Performance (2017-2022)
9.15.4 Recent Development
9.15.5 SWOT Analysis
9.16 OSI Pharmaceuticals, Inc.
9.16.1 OSI Pharmaceuticals, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.16.2 Antiandrogen Monotherapy Product Profiles, Application and Specification
9.16.3 OSI Pharmaceuticals, Inc. Market Performance (2017-2022)
9.16.4 Recent Development
9.16.5 SWOT Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Data Source
LIST OF TABLES AND FIGURES
Figure Antiandrogen Monotherapy Product Picture
Table Global Antiandrogen Monotherapy Market Sales Volume and CAGR (%) Comparison by Type
Table Antiandrogen Monotherapy Market Consumption (Sales Volume) Comparison by Application (2017-2027)
Figure Global Antiandrogen Monotherapy Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)
Figure United States Antiandrogen Monotherapy Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Europe Antiandrogen Monotherapy Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Antiandrogen Monotherapy Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Antiandrogen Monotherapy Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Antiandrogen Monotherapy Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Antiandrogen Monotherapy Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Latin America Antiandrogen Monotherapy Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Middle East and Africa Antiandrogen Monotherapy Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Global Antiandrogen Monotherapy Market Sales Volume Status and Outlook (2017-2027)
Table Global Macroeconomic Analysis
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Antiandrogen Monotherapy Industry Development
Table Global Antiandrogen Monotherapy Sales Volume by Player (2017-2022)
Table Global Antiandrogen Monotherapy Sales Volume Share by Player (2017-2022)
Figure Global Antiandrogen Monotherapy Sales Volume Share by Player in 2021
Table Antiandrogen Monotherapy Revenue (Million USD) by Player (2017-2022)
Table Antiandrogen Monotherapy Revenue Market Share by Player (2017-2022)
Table Antiandrogen Monotherapy Price by Player (2017-2022)
Table Antiandrogen Monotherapy Gross Margin by Player (2017-2022)
Table Mergers & Acquisitions, Expansion Plans
Table Global Antiandrogen Monotherapy Sales Volume, Region Wise (2017-2022)
Table Global Antiandrogen Monotherapy Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Antiandrogen Monotherapy Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Antiandrogen Monotherapy Sales Volume Market Share, Region Wise in 2021
Table Global Antiandrogen Monotherapy Revenue (Million USD), Region Wise (2017-2022)
Table Global Antiandrogen Monotherapy Revenue Market Share, Region Wise (2017-2022)
Figure Global Antiandrogen Monotherapy Revenue Market Share, Region Wise (2017-2022)
Figure Global Antiandrogen Monotherapy Revenue Market Share, Region Wise in 2021
Table Global Antiandrogen Monotherapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table United States Antiandrogen Monotherapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Europe Antiandrogen Monotherapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table China Antiandrogen Monotherapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Japan Antiandrogen Monotherapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table India Antiandrogen Monotherapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Southeast Asia Antiandrogen Monotherapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Latin America Antiandrogen Monotherapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Middle East and Africa Antiandrogen Monotherapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Global Antiandrogen Monotherapy Sales Volume by Type (2017-2022)
Table Global Antiandrogen Monotherapy Sales Volume Market Share by Type (2017-2022)
Figure Global Antiandrogen Monotherapy Sales Volume Market Share by Type in 2021
Table Global Antiandrogen Monotherapy Revenue (Million USD) by Type (2017-2022)
Table Global Antiandrogen Monotherapy Revenue Market Share by Type (2017-2022)
Figure Global Antiandrogen Monotherapy Revenue Market Share by Type in 2021
Table Antiandrogen Monotherapy Price by Type (2017-2022)
Figure Global Antiandrogen Monotherapy Sales Volume and Growth Rate of Steroidal (2017-2022)
Figure Global Antiandrogen Monotherapy Revenue (Million USD) and Growth Rate of Steroidal (2017-2022)
Figure Global Antiandrogen Monotherapy Sales Volume and Growth Rate of Nonsteroidal (2017-2022)
Figure Global Antiandrogen Monotherapy Revenue (Million USD) and Growth Rate of Nonsteroidal (2017-2022)
Table Global Antiandrogen Monotherapy Consumption by Application (2017-2022)
Table Global Antiandrogen Monotherapy Consumption Market Share by Application (2017-2022)
Table Global Antiandrogen Monotherapy Consumption Revenue (Million USD) by Application (2017-2022)
Table Global Antiandrogen Monotherapy Consumption Revenue Market Share by Application (2017-2022)
Table Global Antiandrogen Monotherapy Consumption and Growth Rate of Prostate Cancer (2017-2022)
Table Global Antiandrogen Monotherapy Consumption and Growth Rate of Benign Prostatic Hyperplasia (2017-2022)
Table Global Antiandrogen Monotherapy Consumption and Growth Rate of Hirsutism (2017-2022)
Table Global Antiandrogen Monotherapy Consumption and Growth Rate of Hyperandrogenism (2017-2022)
Table Global Antiandrogen Monotherapy Consumption and Growth Rate of Others (2017-2022)
Figure Global Antiandrogen Monotherapy Sales Volume and Growth Rate Forecast (2022-2027)
Figure Global Antiandrogen Monotherapy Revenue (Million USD) and Growth Rate Forecast (2022-2027)
Figure Global Antiandrogen Monotherapy Price and Trend Forecast (2022-2027)
Figure USA Antiandrogen Monotherapy Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure USA Antiandrogen Monotherapy Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Antiandrogen Monotherapy Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Antiandrogen Monotherapy Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure China Antiandrogen Monotherapy Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure China Antiandrogen Monotherapy Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Antiandrogen Monotherapy Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Antiandrogen Monotherapy Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure India Antiandrogen Monotherapy Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure India Antiandrogen Monotherapy Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Antiandrogen Monotherapy Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Antiandrogen Monotherapy Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Antiandrogen Monotherapy Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Antiandrogen Monotherapy Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Antiandrogen Monotherapy Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Antiandrogen Monotherapy Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Table Global Antiandrogen Monotherapy Market Sales Volume Forecast, by Type
Table Global Antiandrogen Monotherapy Sales Volume Market Share Forecast, by Type
Table Global Antiandrogen Monotherapy Market Revenue (Million USD) Forecast, by Type
Table Global Antiandrogen Monotherapy Revenue Market Share Forecast, by Type
Table Global Antiandrogen Monotherapy Price Forecast, by Type
Figure Global Antiandrogen Monotherapy Revenue (Million USD) and Growth Rate of Steroidal (2022-2027)
Figure Global Antiandrogen Monotherapy Revenue (Million USD) and Growth Rate of Steroidal (2022-2027)
Figure Global Antiandrogen Monotherapy Revenue (Million USD) and Growth Rate of Nonsteroidal (2022-2027)
Figure Global Antiandrogen Monotherapy Revenue (Million USD) and Growth Rate of Nonsteroidal (2022-2027)
Table Global Antiandrogen Monotherapy Market Consumption Forecast, by Application
Table Global Antiandrogen Monotherapy Consumption Market Share Forecast, by Application
Table Global Antiandrogen Monotherapy Market Revenue (Million USD) Forecast, by Application
Table Global Antiandrogen Monotherapy Revenue Market Share Forecast, by Application
Figure Global Antiandrogen Monotherapy Consumption Value (Million USD) and Growth Rate of Prostate Cancer (2022-2027)
Figure Global Antiandrogen Monotherapy Consumption Value (Million USD) and Growth Rate of Benign Prostatic Hyperplasia (2022-2027)
Figure Global Antiandrogen Monotherapy Consumption Value (Million USD) and Growth Rate of Hirsutism (2022-2027)
Figure Global Antiandrogen Monotherapy Consumption Value (Million USD) and Growth Rate of Hyperandrogenism (2022-2027)
Figure Global Antiandrogen Monotherapy Consumption Value (Million USD) and Growth Rate of Others (2022-2027)
Figure Antiandrogen Monotherapy Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Manufacturing Cost Structure Analysis
Table Alternative Product Analysis
Table Downstream Distributors
Table Downstream Buyers
Table Abbott Laboratories Profile
Table Abbott Laboratories Antiandrogen Monotherapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Abbott Laboratories Antiandrogen Monotherapy Sales Volume and Growth Rate
Figure Abbott Laboratories Revenue (Million USD) Market Share 2017-2022
Table Progenics Pharmaceuticals, Inc. Profile
Table Progenics Pharmaceuticals, Inc. Antiandrogen Monotherapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Progenics Pharmaceuticals, Inc. Antiandrogen Monotherapy Sales Volume and Growth Rate
Figure Progenics Pharmaceuticals, Inc. Revenue (Million USD) Market Share 2017-2022
Table ANI Pharmaceuticals, Inc. Profile
Table ANI Pharmaceuticals, Inc. Antiandrogen Monotherapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure ANI Pharmaceuticals, Inc. Antiandrogen Monotherapy Sales Volume and Growth Rate
Figure ANI Pharmaceuticals, Inc. Revenue (Million USD) Market Share 2017-2022
Table Sanofi SA Profile
Table Sanofi SA Antiandrogen Monotherapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Sanofi SA Antiandrogen Monotherapy Sales Volume and Growth Rate
Figure Sanofi SA Revenue (Million USD) Market Share 2017-2022
Table Novartis AG Profile
Table Novartis AG Antiandrogen Monotherapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Novartis AG Antiandrogen Monotherapy Sales Volume and Growth Rate
Figure Novartis AG Revenue (Million USD) Market Share 2017-2022
Table Pfizer Inc. Profile
Table Pfizer Inc. Antiandrogen Monotherapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Pfizer Inc. Antiandrogen Monotherapy Sales Volume and Growth Rate
Figure Pfizer Inc. Revenue (Million USD) Market Share 2017-2022
Table GlaxoSmithKline Plc Profile
Table GlaxoSmithKline Plc Antiandrogen Monotherapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure GlaxoSmithKline Plc Antiandrogen Monotherapy Sales Volume and Growth Rate
Figure GlaxoSmithKline Plc Revenue (Million USD) Market Share 2017-2022
Table Genentech Inc. Profile
Table Genentech Inc. Antiandrogen Monotherapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Genentech Inc. Antiandrogen Monotherapy Sales Volume and Growth Rate
Figure Genentech Inc. Revenue (Million USD) Market Share 2017-2022
Table Bristol-Myers Squibb Company Profile
Table Bristol-Myers Squibb Company Antiandrogen Monotherapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Bristol-Myers Squibb Company Antiandrogen Monotherapy Sales Volume and Growth Rate
Figure Bristol-Myers Squibb Company Revenue (Million USD) Market Share 2017-2022
Table Astellas Pharma Inc. Profile
Table Astellas Pharma Inc. Antiandrogen Monotherapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Astellas Pharma Inc. Antiandrogen Monotherapy Sales Volume and Growth Rate
Figure Astellas Pharma Inc. Revenue (Million USD) Market Share 2017-2022
Table ALZA Corporation Profile
Table ALZA Corporation Antiandrogen Monotherapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure ALZA Corporation Antiandrogen Monotherapy Sales Volume and Growth Rate
Figure ALZA Corporation Revenue (Million USD) Market Share 2017-2022
Table Takeda Pharmaceutical Company Limited Profile
Table Takeda Pharmaceutical Company Limited Antiandrogen Monotherapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Takeda Pharmaceutical Company Limited Antiandrogen Monotherapy Sales Volume and Growth Rate
Figure Takeda Pharmaceutical Company Limited Revenue (Million USD) Market Share 2017-2022
Table Amgen Inc Profile
Table Amgen Inc Antiandrogen Monotherapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Amgen Inc Antiandrogen Monotherapy Sales Volume and Growth Rate
Figure Amgen Inc Revenue (Million USD) Market Share 2017-2022
Table F. Hoffmann-La Roche Ltd. Profile
Table F. Hoffmann-La Roche Ltd. Antiandrogen Monotherapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure F. Hoffmann-La Roche Ltd. Antiandrogen Monotherapy Sales Volume and Growth Rate
Figure F. Hoffmann-La Roche Ltd. Revenue (Million USD) Market Share 2017-2022
Table AstraZeneca Plc Profile
Table AstraZeneca Plc Antiandrogen Monotherapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure AstraZeneca Plc Antiandrogen Monotherapy Sales Volume and Growth Rate
Figure AstraZeneca Plc Revenue (Million USD) Market Share 2017-2022
Table OSI Pharmaceuticals, Inc. Profile
Table OSI Pharmaceuticals, Inc. Antiandrogen Monotherapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure OSI Pharmaceuticals, Inc. Antiandrogen Monotherapy Sales Volume and Growth Rate
Figure OSI Pharmaceuticals, Inc. Revenue (Million USD) Market Share 2017-2022
Figure Antiandrogen Monotherapy Product Picture
Table Global Antiandrogen Monotherapy Market Sales Volume and CAGR (%) Comparison by Type
Table Antiandrogen Monotherapy Market Consumption (Sales Volume) Comparison by Application (2017-2027)
Figure Global Antiandrogen Monotherapy Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)
Figure United States Antiandrogen Monotherapy Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Europe Antiandrogen Monotherapy Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Antiandrogen Monotherapy Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Antiandrogen Monotherapy Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Antiandrogen Monotherapy Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Antiandrogen Monotherapy Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Latin America Antiandrogen Monotherapy Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Middle East and Africa Antiandrogen Monotherapy Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Global Antiandrogen Monotherapy Market Sales Volume Status and Outlook (2017-2027)
Table Global Macroeconomic Analysis
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Antiandrogen Monotherapy Industry Development
Table Global Antiandrogen Monotherapy Sales Volume by Player (2017-2022)
Table Global Antiandrogen Monotherapy Sales Volume Share by Player (2017-2022)
Figure Global Antiandrogen Monotherapy Sales Volume Share by Player in 2021
Table Antiandrogen Monotherapy Revenue (Million USD) by Player (2017-2022)
Table Antiandrogen Monotherapy Revenue Market Share by Player (2017-2022)
Table Antiandrogen Monotherapy Price by Player (2017-2022)
Table Antiandrogen Monotherapy Gross Margin by Player (2017-2022)
Table Mergers & Acquisitions, Expansion Plans
Table Global Antiandrogen Monotherapy Sales Volume, Region Wise (2017-2022)
Table Global Antiandrogen Monotherapy Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Antiandrogen Monotherapy Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Antiandrogen Monotherapy Sales Volume Market Share, Region Wise in 2021
Table Global Antiandrogen Monotherapy Revenue (Million USD), Region Wise (2017-2022)
Table Global Antiandrogen Monotherapy Revenue Market Share, Region Wise (2017-2022)
Figure Global Antiandrogen Monotherapy Revenue Market Share, Region Wise (2017-2022)
Figure Global Antiandrogen Monotherapy Revenue Market Share, Region Wise in 2021
Table Global Antiandrogen Monotherapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table United States Antiandrogen Monotherapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Europe Antiandrogen Monotherapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table China Antiandrogen Monotherapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Japan Antiandrogen Monotherapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table India Antiandrogen Monotherapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Southeast Asia Antiandrogen Monotherapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Latin America Antiandrogen Monotherapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Middle East and Africa Antiandrogen Monotherapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Global Antiandrogen Monotherapy Sales Volume by Type (2017-2022)
Table Global Antiandrogen Monotherapy Sales Volume Market Share by Type (2017-2022)
Figure Global Antiandrogen Monotherapy Sales Volume Market Share by Type in 2021
Table Global Antiandrogen Monotherapy Revenue (Million USD) by Type (2017-2022)
Table Global Antiandrogen Monotherapy Revenue Market Share by Type (2017-2022)
Figure Global Antiandrogen Monotherapy Revenue Market Share by Type in 2021
Table Antiandrogen Monotherapy Price by Type (2017-2022)
Figure Global Antiandrogen Monotherapy Sales Volume and Growth Rate of Steroidal (2017-2022)
Figure Global Antiandrogen Monotherapy Revenue (Million USD) and Growth Rate of Steroidal (2017-2022)
Figure Global Antiandrogen Monotherapy Sales Volume and Growth Rate of Nonsteroidal (2017-2022)
Figure Global Antiandrogen Monotherapy Revenue (Million USD) and Growth Rate of Nonsteroidal (2017-2022)
Table Global Antiandrogen Monotherapy Consumption by Application (2017-2022)
Table Global Antiandrogen Monotherapy Consumption Market Share by Application (2017-2022)
Table Global Antiandrogen Monotherapy Consumption Revenue (Million USD) by Application (2017-2022)
Table Global Antiandrogen Monotherapy Consumption Revenue Market Share by Application (2017-2022)
Table Global Antiandrogen Monotherapy Consumption and Growth Rate of Prostate Cancer (2017-2022)
Table Global Antiandrogen Monotherapy Consumption and Growth Rate of Benign Prostatic Hyperplasia (2017-2022)
Table Global Antiandrogen Monotherapy Consumption and Growth Rate of Hirsutism (2017-2022)
Table Global Antiandrogen Monotherapy Consumption and Growth Rate of Hyperandrogenism (2017-2022)
Table Global Antiandrogen Monotherapy Consumption and Growth Rate of Others (2017-2022)
Figure Global Antiandrogen Monotherapy Sales Volume and Growth Rate Forecast (2022-2027)
Figure Global Antiandrogen Monotherapy Revenue (Million USD) and Growth Rate Forecast (2022-2027)
Figure Global Antiandrogen Monotherapy Price and Trend Forecast (2022-2027)
Figure USA Antiandrogen Monotherapy Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure USA Antiandrogen Monotherapy Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Antiandrogen Monotherapy Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Antiandrogen Monotherapy Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure China Antiandrogen Monotherapy Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure China Antiandrogen Monotherapy Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Antiandrogen Monotherapy Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Antiandrogen Monotherapy Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure India Antiandrogen Monotherapy Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure India Antiandrogen Monotherapy Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Antiandrogen Monotherapy Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Antiandrogen Monotherapy Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Antiandrogen Monotherapy Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Antiandrogen Monotherapy Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Antiandrogen Monotherapy Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Antiandrogen Monotherapy Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Table Global Antiandrogen Monotherapy Market Sales Volume Forecast, by Type
Table Global Antiandrogen Monotherapy Sales Volume Market Share Forecast, by Type
Table Global Antiandrogen Monotherapy Market Revenue (Million USD) Forecast, by Type
Table Global Antiandrogen Monotherapy Revenue Market Share Forecast, by Type
Table Global Antiandrogen Monotherapy Price Forecast, by Type
Figure Global Antiandrogen Monotherapy Revenue (Million USD) and Growth Rate of Steroidal (2022-2027)
Figure Global Antiandrogen Monotherapy Revenue (Million USD) and Growth Rate of Steroidal (2022-2027)
Figure Global Antiandrogen Monotherapy Revenue (Million USD) and Growth Rate of Nonsteroidal (2022-2027)
Figure Global Antiandrogen Monotherapy Revenue (Million USD) and Growth Rate of Nonsteroidal (2022-2027)
Table Global Antiandrogen Monotherapy Market Consumption Forecast, by Application
Table Global Antiandrogen Monotherapy Consumption Market Share Forecast, by Application
Table Global Antiandrogen Monotherapy Market Revenue (Million USD) Forecast, by Application
Table Global Antiandrogen Monotherapy Revenue Market Share Forecast, by Application
Figure Global Antiandrogen Monotherapy Consumption Value (Million USD) and Growth Rate of Prostate Cancer (2022-2027)
Figure Global Antiandrogen Monotherapy Consumption Value (Million USD) and Growth Rate of Benign Prostatic Hyperplasia (2022-2027)
Figure Global Antiandrogen Monotherapy Consumption Value (Million USD) and Growth Rate of Hirsutism (2022-2027)
Figure Global Antiandrogen Monotherapy Consumption Value (Million USD) and Growth Rate of Hyperandrogenism (2022-2027)
Figure Global Antiandrogen Monotherapy Consumption Value (Million USD) and Growth Rate of Others (2022-2027)
Figure Antiandrogen Monotherapy Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Manufacturing Cost Structure Analysis
Table Alternative Product Analysis
Table Downstream Distributors
Table Downstream Buyers
Table Abbott Laboratories Profile
Table Abbott Laboratories Antiandrogen Monotherapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Abbott Laboratories Antiandrogen Monotherapy Sales Volume and Growth Rate
Figure Abbott Laboratories Revenue (Million USD) Market Share 2017-2022
Table Progenics Pharmaceuticals, Inc. Profile
Table Progenics Pharmaceuticals, Inc. Antiandrogen Monotherapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Progenics Pharmaceuticals, Inc. Antiandrogen Monotherapy Sales Volume and Growth Rate
Figure Progenics Pharmaceuticals, Inc. Revenue (Million USD) Market Share 2017-2022
Table ANI Pharmaceuticals, Inc. Profile
Table ANI Pharmaceuticals, Inc. Antiandrogen Monotherapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure ANI Pharmaceuticals, Inc. Antiandrogen Monotherapy Sales Volume and Growth Rate
Figure ANI Pharmaceuticals, Inc. Revenue (Million USD) Market Share 2017-2022
Table Sanofi SA Profile
Table Sanofi SA Antiandrogen Monotherapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Sanofi SA Antiandrogen Monotherapy Sales Volume and Growth Rate
Figure Sanofi SA Revenue (Million USD) Market Share 2017-2022
Table Novartis AG Profile
Table Novartis AG Antiandrogen Monotherapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Novartis AG Antiandrogen Monotherapy Sales Volume and Growth Rate
Figure Novartis AG Revenue (Million USD) Market Share 2017-2022
Table Pfizer Inc. Profile
Table Pfizer Inc. Antiandrogen Monotherapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Pfizer Inc. Antiandrogen Monotherapy Sales Volume and Growth Rate
Figure Pfizer Inc. Revenue (Million USD) Market Share 2017-2022
Table GlaxoSmithKline Plc Profile
Table GlaxoSmithKline Plc Antiandrogen Monotherapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure GlaxoSmithKline Plc Antiandrogen Monotherapy Sales Volume and Growth Rate
Figure GlaxoSmithKline Plc Revenue (Million USD) Market Share 2017-2022
Table Genentech Inc. Profile
Table Genentech Inc. Antiandrogen Monotherapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Genentech Inc. Antiandrogen Monotherapy Sales Volume and Growth Rate
Figure Genentech Inc. Revenue (Million USD) Market Share 2017-2022
Table Bristol-Myers Squibb Company Profile
Table Bristol-Myers Squibb Company Antiandrogen Monotherapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Bristol-Myers Squibb Company Antiandrogen Monotherapy Sales Volume and Growth Rate
Figure Bristol-Myers Squibb Company Revenue (Million USD) Market Share 2017-2022
Table Astellas Pharma Inc. Profile
Table Astellas Pharma Inc. Antiandrogen Monotherapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Astellas Pharma Inc. Antiandrogen Monotherapy Sales Volume and Growth Rate
Figure Astellas Pharma Inc. Revenue (Million USD) Market Share 2017-2022
Table ALZA Corporation Profile
Table ALZA Corporation Antiandrogen Monotherapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure ALZA Corporation Antiandrogen Monotherapy Sales Volume and Growth Rate
Figure ALZA Corporation Revenue (Million USD) Market Share 2017-2022
Table Takeda Pharmaceutical Company Limited Profile
Table Takeda Pharmaceutical Company Limited Antiandrogen Monotherapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Takeda Pharmaceutical Company Limited Antiandrogen Monotherapy Sales Volume and Growth Rate
Figure Takeda Pharmaceutical Company Limited Revenue (Million USD) Market Share 2017-2022
Table Amgen Inc Profile
Table Amgen Inc Antiandrogen Monotherapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Amgen Inc Antiandrogen Monotherapy Sales Volume and Growth Rate
Figure Amgen Inc Revenue (Million USD) Market Share 2017-2022
Table F. Hoffmann-La Roche Ltd. Profile
Table F. Hoffmann-La Roche Ltd. Antiandrogen Monotherapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure F. Hoffmann-La Roche Ltd. Antiandrogen Monotherapy Sales Volume and Growth Rate
Figure F. Hoffmann-La Roche Ltd. Revenue (Million USD) Market Share 2017-2022
Table AstraZeneca Plc Profile
Table AstraZeneca Plc Antiandrogen Monotherapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure AstraZeneca Plc Antiandrogen Monotherapy Sales Volume and Growth Rate
Figure AstraZeneca Plc Revenue (Million USD) Market Share 2017-2022
Table OSI Pharmaceuticals, Inc. Profile
Table OSI Pharmaceuticals, Inc. Antiandrogen Monotherapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure OSI Pharmaceuticals, Inc. Antiandrogen Monotherapy Sales Volume and Growth Rate
Figure OSI Pharmaceuticals, Inc. Revenue (Million USD) Market Share 2017-2022
